Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Hemispherx Biopharma (HEB)

0.3292 +0.0092 (+2.8750%)

9/20/2017  3:58pm

Open:

0.3200

Pre. Close:

0.3200

High:

0.3399

Low:

0.3100

Volume:

209,129

Market Cap:

9.60M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.35 - 0.36

0.36 - 0.38

Low:

0.3 - 0.3

0.3 - 0.31

Close:

0.32 - 0.33

0.33 - 0.35

Technical analysis  (as of: 2017-09-20 4:38:53 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.43     One year: 0.48

Support:

Support1: 0.30    Support2: 0.25

Resistance:

Resistance1: 0.37    Resistance2: 0.41

Pivot:

0.34

Moving Averages:

MA(5): 0.33     MA(20): 0.35

MA(100): 0.47     MA(250): 0.64

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 29.57     %D(3): 28.99

RSI:

RSI(14): 40.03

52-Week:

High: 1.3600  Low: 0.3000  Change(%): -74.9

Average Vol(K):

3-Month: 30242  10-Days 21408

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
HEB has closed above bottom band by 32.4%. Bollinger Bands are 34.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 11 Aug 2017 14:15:00 GMT
Hemispherx Biopharma to Host Conference Call to Discuss Second Quarter ...

Wed, 31 Aug 2016 12:22:30 GMT
Hemispherx Biopharma, Inc. Announces $5 Million Registered Direct Offering

Wed, 17 Aug 2016 20:15:00 GMT
Hemispherx Biopharma Announces 1-for-12 Reverse Stock Split

Tue, 15 Aug 2017 19:18:45 GMT
Hemispherx Biopharma's (HEB) CEO Thomas Equels on Q2 2017 Results - Earnings ...

Wed, 20 Sep 2017 19:52:30 GMT
Hemispherx Biopharma Inc (HEB) Moves 2.81%

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

29.17

Shares Float (M)

28.52

% Held by Insiders

4.79

% Held by Institutions

10.40

Shares Short (K)

783

Shares Short Prior Month (K)

854

Stock Financials

EPS

-0.370

EPS Est. Current Year

EPS Est. Next Year

-0.030

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

0.360

PEG Ratio

Profit Margin

Operating Margin

-3924.78

Return on Assets (ttm)

-43.2

Return on Equity (ttm)

-65.1

Qtrly Rev. Growth

1320.0

Gross Profit (p.s.)

-0.035

Sales Per Share

EBITDA (p.s.)

-0.415

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.39

Levered Free Cash Flow (M)

-5.95

FoxReading.com

Valuation

P/E

-0.89

P/E Growth Ratio

0.03

P/BV

0.91

P/S

960276416.00

P/CF

-0.92

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-08-29

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.